Autopsy report · NCT05033314
THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
Cause of deathSlow enrollment
“Study terminated due to slow recruitment.”
Life of this trial
- Registered 10 months before it started.
- Ran for about 2 years 4 months before it stopped.
- 4 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- University Health Network, Toronto
- Sponsor type
- University, hospital or other
- Conditions
- Sickle Cell Disease; Central Venous Catheter Thrombosis; Venous Thromboembolism
- Interventions
- Rivaroxaban 10 MG; Placebo
- Participants
- 4
- Sites
- 3
- Countries
- Canada
Trials that died the same way
- Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab
“Study was terminated early because of slow recruitment” - A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
“Study terminated due to slow patient recruitment.” - Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
“Slow recruitment; Study was terminated for futility reasons” - Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
“Study terminated prematurely due to poor recruitment.” - Alfuzosin Versus Placebo in Acute Urinary Retention
“The study was early terminated due to slow and difficult recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.